Gasmi Mehdi
Insider CIK 1614875 · AAVL VP, Pharmaceutical Development, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ADVM Adverum Biotechnologies, I | A Award deriv | 2021-05-12 | 2021-05-14 | 40,000 | — | $0 | 40,000 | SEC↗ |
| ADVM Adverum Biotechnologies, I | M Exercise deriv | 2020-07-20 | 2020-07-22 | 5,000 | — | $0 | 78,000 | SEC↗ |
| ADVM Adverum Biotechnologies, I | S Sale | 2020-07-20 | 2020-07-22 | 5,000 | $17.60 | $88.0K | 274,442 | SEC↗ |
| ADVM Adverum Biotechnologies, I | M Exercise | 2020-07-20 | 2020-07-22 | 5,000 | $4.80 | $24.0K | 279,442 | SEC↗ |
| ADVM Adverum Biotechnologies, I | A Award deriv | 2020-06-23 | 2020-06-25 | 30,000 | — | $0 | 30,000 | SEC↗ |
| ADVM Adverum Biotechnologies, I | M Exercise deriv | 2020-06-22 | 2020-06-23 | 23,605 | — | $0 | 83,000 | SEC↗ |
| ADVM Adverum Biotechnologies, I | S Sale | 2020-06-22 | 2020-06-23 | 23,605 | $25.06 | $591.5K | 274,442 | SEC↗ |
| ADVM Adverum Biotechnologies, I | M Exercise | 2020-06-22 | 2020-06-23 | 23,605 | $4.80 | $113.3K | 298,047 | SEC↗ |
| ADVM Adverum Biotechnologies, I | M Exercise deriv | 2020-06-18 | 2020-06-18 | 11,127 | — | $0 | 106,605 | SEC↗ |
| ADVM Adverum Biotechnologies, I | S Sale | 2020-06-18 | 2020-06-18 | 11,127 | $25.01 | $278.3K | 274,442 | SEC↗ |
| ADVM Adverum Biotechnologies, I | M Exercise | 2020-06-18 | 2020-06-18 | 11,127 | $4.80 | $53.4K | 285,569 | SEC↗ |
| ADVM Adverum Biotechnologies, I | M Exercise deriv | 2020-06-17 | 2020-06-18 | 268 | — | $0 | 117,732 | SEC↗ |
| ADVM Adverum Biotechnologies, I | M Exercise | 2020-06-17 | 2020-06-18 | 268 | $4.80 | $1.3K | 274,710 | SEC↗ |
| ADVM Adverum Biotechnologies, I | S Sale | 2020-06-17 | 2020-06-18 | 268 | $25.01 | $6.7K | 274,442 | SEC↗ |
| ADVM Adverum Biotechnologies, I | M Exercise deriv | 2020-06-15 | 2020-06-17 | 10,000 | — | $0 | 118,000 | SEC↗ |
| ADVM Adverum Biotechnologies, I | S Sale | 2020-06-15 | 2020-06-17 | 1,416 | $21.93 | $31.1K | 278,026 | SEC↗ |
| ADVM Adverum Biotechnologies, I | M Exercise | 2020-06-15 | 2020-06-17 | 10,000 | $4.80 | $48.0K | 284,442 | SEC↗ |
| ADVM Adverum Biotechnologies, I | S Sale | 2020-06-15 | 2020-06-17 | 5,000 | $21.01 | $105.1K | 279,442 | SEC↗ |
| ADVM Adverum Biotechnologies, I | S Sale | 2020-06-15 | 2020-06-17 | 159 | $23.59 | $3.8K | 274,442 | SEC↗ |
| ADVM Adverum Biotechnologies, I | S Sale | 2020-06-15 | 2020-06-17 | 3,425 | $23.00 | $78.8K | 274,601 | SEC↗ |
| ADVM Adverum Biotechnologies, I | M Exercise deriv | 2020-05-21 | 2020-05-22 | 3,599 | — | $0 | 128,000 | SEC↗ |
| ADVM Adverum Biotechnologies, I | M Exercise | 2020-05-21 | 2020-05-22 | 3,599 | $4.80 | $17.3K | 278,041 | SEC↗ |
| ADVM Adverum Biotechnologies, I | S Sale | 2020-05-21 | 2020-05-22 | 3,599 | $20.02 | $72.1K | 274,442 | SEC↗ |
| ADVM Adverum Biotechnologies, I | M Exercise deriv | 2020-05-20 | 2020-05-22 | 1,401 | — | $0 | 131,599 | SEC↗ |
| ADVM Adverum Biotechnologies, I | M Exercise | 2020-05-20 | 2020-05-22 | 1,401 | $4.80 | $6.7K | 275,843 | SEC↗ |
| ADVM Adverum Biotechnologies, I | S Sale | 2020-05-20 | 2020-05-22 | 1,401 | $20.01 | $28.0K | 274,442 | SEC↗ |
| ADVM Adverum Biotechnologies, I | M Exercise deriv | 2020-05-18 | 2020-05-20 | 5,000 | — | $0 | 133,000 | SEC↗ |
| ADVM Adverum Biotechnologies, I | M Exercise | 2020-05-18 | 2020-05-20 | 5,000 | $4.80 | $24.0K | 279,442 | SEC↗ |
| ADVM Adverum Biotechnologies, I | S Sale | 2020-05-18 | 2020-05-20 | 4,700 | $18.11 | $85.1K | 274,742 | SEC↗ |
| ADVM Adverum Biotechnologies, I | S Sale | 2020-05-18 | 2020-05-20 | 300 | $19.03 | $5.7K | 274,442 | SEC↗ |
| ADVM Adverum Biotechnologies, I | M Exercise deriv | 2020-05-06 | 2020-05-20 | 25,000 | — | $0 | 138,000 | SEC↗ |
| ADVM Adverum Biotechnologies, I | M Exercise | 2020-05-06 | 2020-05-20 | 25,000 | $4.80 | $120.0K | 299,442 | SEC↗ |
| ADVM Adverum Biotechnologies, I | S Sale | 2020-05-06 | 2020-05-20 | 25,000 | $20.03 | $500.8K | 274,442 | SEC↗ |
| ADVM Adverum Biotechnologies, I | M Exercise deriv | 2020-05-05 | 2020-05-20 | 10,000 | — | $0 | 163,000 | SEC↗ |
| ADVM Adverum Biotechnologies, I | S Sale | 2020-05-05 | 2020-05-20 | 10,000 | $16.26 | $162.6K | 274,442 | SEC↗ |
| ADVM Adverum Biotechnologies, I | M Exercise | 2020-05-05 | 2020-05-20 | 10,000 | $4.80 | $48.0K | 284,442 | SEC↗ |
| ADVM Adverum Biotechnologies, I | M Exercise deriv | 2020-02-18 | 2020-02-20 | 5,000 | — | $0 | 173,000 | SEC↗ |
| ADVM Adverum Biotechnologies, I | M Exercise | 2020-02-18 | 2020-02-20 | 5,000 | $4.80 | $24.0K | 263,979 | SEC↗ |
| ADVM Adverum Biotechnologies, I | S Sale | 2020-02-18 | 2020-02-20 | 5,000 | $16.23 | $81.2K | 258,979 | SEC↗ |
| ADVM Adverum Biotechnologies, I | M Exercise deriv | 2020-02-12 | 2020-05-20 | 10,000 | — | $0 | 178,000 | SEC↗ |
| ADVM Adverum Biotechnologies, I | S Sale | 2020-02-12 | 2020-05-20 | 10,000 | $15.07 | $150.7K | 274,442 | SEC↗ |
| ADVM Adverum Biotechnologies, I | M Exercise | 2020-02-12 | 2020-05-20 | 10,000 | $4.80 | $48.0K | 284,442 | SEC↗ |
| ADVM Adverum Biotechnologies, I | F Tax w/h | 2020-02-12 | 2020-05-20 | 15,494 | $15.05 | $233.2K | 274,442 | SEC↗ |
| ADVM Adverum Biotechnologies, I | F Tax w/h | 2020-02-12 | 2020-05-20 | 31,482 | $11.33 | $356.7K | 289,936 | SEC↗ |
| ADVM Adverum Biotechnologies, I | M Exercise deriv | 2020-02-12 | 2020-02-14 | 10,000 | — | $0 | 178,000 | SEC↗ |
| ADVM Adverum Biotechnologies, I | M Exercise | 2020-02-12 | 2020-02-14 | 10,000 | $4.80 | $48.0K | 268,979 | SEC↗ |
| ADVM Adverum Biotechnologies, I | S Sale | 2020-02-12 | 2020-02-14 | 10,000 | $15.07 | $150.7K | 258,979 | SEC↗ |
| ADVM Adverum Biotechnologies, I | F Tax w/h | 2020-02-12 | 2020-02-14 | 31,451 | $11.33 | $356.3K | 289,967 | SEC↗ |
| ADVM Adverum Biotechnologies, I | F Tax w/h | 2020-02-12 | 2020-02-14 | 15,494 | $15.05 | $233.2K | 258,979 | SEC↗ |
| ADVM Adverum Biotechnologies, I | F Tax w/h | 2020-02-09 | 2020-02-10 | 11,551 | $10.24 | $118.3K | 309,867 | SEC↗ |
| ADVM Adverum Biotechnologies, I | F Tax w/h | 2020-02-09 | 2020-02-14 | 15,494 | $10.24 | $158.7K | 274,473 | SEC↗ |
| ADVM Adverum Biotechnologies, I | A Award | 2020-01-15 | 2020-05-20 | 88,496 | — | $0 | 321,418 | SEC↗ |
| ADVM Adverum Biotechnologies, I | A Award | 2020-01-15 | 2020-02-14 | 88,496 | — | $0 | 321,418 | SEC↗ |
| ADVM Adverum Biotechnologies, I | F Tax w/h | 2019-04-21 | 2020-02-10 | 589 | $5.98 | $3.5K | 321,418 | SEC↗ |
| ADVM Adverum Biotechnologies, I | A Award deriv | 2019-02-14 | 2019-02-19 | 225,000 | — | $0 | 225,000 | SEC↗ |
| ADVM Adverum Biotechnologies, I | F Tax w/h | 2019-02-12 | 2020-02-10 | 10,652 | $3.55 | $37.8K | 322,007 | SEC↗ |
| ADVM Adverum Biotechnologies, I | F Tax w/h | 2019-02-09 | 2020-02-10 | 12,599 | $3.33 | $42.0K | 332,659 | SEC↗ |
| ADVM Adverum Biotechnologies, I | A Award | 2018-06-15 | 2020-02-10 | 88,496 | — | $0 | 345,258 | SEC↗ |
| ADVM Adverum Biotechnologies, I | A Award | 2018-06-15 | 2018-06-18 | 88,496 | — | $0 | 387,031 | SEC↗ |
| ADVM Adverum Biotechnologies, I | F Tax w/h | 2018-04-21 | 2020-02-10 | 605 | $6.30 | $3.8K | 247,762 | SEC↗ |
| ADVM Adverum Biotechnologies, I | A Award deriv | 2018-02-15 | 2018-02-20 | 160,000 | — | $0 | 160,000 | SEC↗ |
| ADVM Adverum Biotechnologies, I | F Tax w/h | 2018-02-12 | 2020-02-10 | 10,806 | $6.85 | $74.0K | 248,367 | SEC↗ |
| ADVM Adverum Biotechnologies, I | F Tax w/h | 2018-02-09 | 2020-02-10 | 11,433 | $7.05 | $80.6K | 259,173 | SEC↗ |
| ADVM Adverum Biotechnologies, I | F Tax w/h | 2017-08-21 | 2020-02-10 | 5,479 | $2.50 | $13.7K | 270,606 | SEC↗ |
| ADVM Adverum Biotechnologies, I | F Tax w/h | 2017-04-21 | 2020-02-10 | 657 | $2.70 | $1.8K | 276,085 | SEC↗ |
| ADVM Adverum Biotechnologies, I | F Tax w/h | 2017-02-12 | 2020-02-10 | 12,793 | $3.00 | $38.4K | 276,742 | SEC↗ |
| ADVM Adverum Biotechnologies, I | A Award deriv | 2017-02-09 | 2017-02-13 | 181,000 | — | $0 | 181,000 | SEC↗ |
| ADVM Adverum Biotechnologies, I | A Award | 2017-02-09 | 2017-02-13 | 125,000 | — | $0 | 289,535 | SEC↗ |
| AAVL Avalanche Biotechnologies, | A Award deriv | 2016-02-12 | 2016-02-17 | 188,000 | — | $0 | 188,000 | SEC↗ |
| AAVL Avalanche Biotechnologies, | A Award | 2016-02-12 | 2016-02-17 | 125,000 | — | $0 | 161,803 | SEC↗ |
| AAVL Avalanche Biotechnologies, | A Award | 2015-08-21 | 2015-08-25 | 29,160 | — | $0 | 36,160 | SEC↗ |
| [AAVL] Avalanche Biotechnologies, | M Exercise deriv | 2015-06-15 | 2015-06-17 | 500 | — | $0 | 95,000 | SEC↗ |
| [AAVL] Avalanche Biotechnologies, | S Sale | 2015-06-15 | 2015-06-17 | 500 | $39.86 | $19.9K | 7,000 | SEC↗ |
| [AAVL] Avalanche Biotechnologies, | M Exercise | 2015-06-15 | 2015-06-17 | 500 | $2.75 | $1.4K | 7,500 | SEC↗ |
| [AAVL] Avalanche Biotechnologies, | M Exercise deriv | 2015-06-08 | 2015-06-10 | 500 | — | $0 | 95,500 | SEC↗ |
| [AAVL] Avalanche Biotechnologies, | M Exercise | 2015-06-08 | 2015-06-10 | 500 | $2.75 | $1.4K | 7,500 | SEC↗ |
| [AAVL] Avalanche Biotechnologies, | S Sale | 2015-06-08 | 2015-06-10 | 82 | $39.88 | $3.3K | 7,000 | SEC↗ |
| [AAVL] Avalanche Biotechnologies, | S Sale | 2015-06-08 | 2015-06-10 | 183 | $38.95 | $7.1K | 7,082 | SEC↗ |
| [AAVL] Avalanche Biotechnologies, | S Sale | 2015-06-08 | 2015-06-10 | 235 | $37.97 | $8.9K | 7,265 | SEC↗ |
| [AAVL] Avalanche Biotechnologies, | M Exercise deriv | 2015-05-28 | 2015-05-29 | 500 | — | $0 | 96,000 | SEC↗ |
| AAVL Avalanche Biotechnologies, | M Exercise deriv | 2015-05-28 | 2015-06-05 | 500 | — | $0 | 96,000 | SEC↗ |
| [AAVL] Avalanche Biotechnologies, | S Sale | 2015-05-28 | 2015-05-29 | 500 | $38.02 | $19.0K | 7,000 | SEC↗ |
| [AAVL] Avalanche Biotechnologies, | M Exercise | 2015-05-28 | 2015-05-29 | 500 | $2.75 | $1.4K | 7,500 | SEC↗ |
| AAVL Avalanche Biotechnologies, | M Exercise | 2015-05-28 | 2015-06-05 | 500 | $2.75 | $1.4K | 7,500 | SEC↗ |
| AAVL Avalanche Biotechnologies, | S Sale | 2015-05-28 | 2015-06-05 | 500 | $38.02 | $19.0K | 7,000 | SEC↗ |
| AAVL Avalanche Biotechnologies, | M Exercise deriv | 2015-05-21 | 2015-05-22 | 500 | — | $0 | 96,500 | SEC↗ |
| AAVL Avalanche Biotechnologies, | S Sale | 2015-05-21 | 2015-05-22 | 500 | $38.87 | $19.4K | 7,000 | SEC↗ |
| AAVL Avalanche Biotechnologies, | M Exercise | 2015-05-21 | 2015-05-22 | 500 | $2.75 | $1.4K | 7,500 | SEC↗ |
| [AAVL] Avalanche Biotechnologies, | M Exercise deriv | 2015-05-14 | 2015-05-15 | 500 | — | $0 | 97,000 | SEC↗ |
| [AAVL] Avalanche Biotechnologies, | M Exercise | 2015-05-14 | 2015-05-15 | 500 | $2.75 | $1.4K | 7,500 | SEC↗ |
| [AAVL] Avalanche Biotechnologies, | S Sale | 2015-05-14 | 2015-05-15 | 500 | $35.31 | $17.7K | 7,000 | SEC↗ |
| AAVL Avalanche Biotechnologies, | M Exercise deriv | 2015-05-07 | 2015-05-08 | 500 | — | $0 | 97,500 | SEC↗ |
| AAVL Avalanche Biotechnologies, | M Exercise | 2015-05-07 | 2015-05-08 | 500 | $2.75 | $1.4K | 7,500 | SEC↗ |
| AAVL Avalanche Biotechnologies, | S Sale | 2015-05-07 | 2015-05-08 | 500 | $33.28 | $16.6K | 7,000 | SEC↗ |
| AAVL Avalanche Biotechnologies, | M Exercise deriv | 2015-04-28 | 2015-04-30 | 1,000 | — | $0 | 98,000 | SEC↗ |
| AAVL Avalanche Biotechnologies, | S Sale | 2015-04-28 | 2015-04-30 | 1,000 | $35.67 | $35.7K | 7,000 | SEC↗ |
| AAVL Avalanche Biotechnologies, | M Exercise | 2015-04-28 | 2015-04-30 | 1,000 | $2.75 | $2.8K | 8,000 | SEC↗ |
| AAVL Avalanche Biotechnologies, | M Exercise deriv | 2015-04-21 | 2015-04-23 | 1,000 | — | $0 | 99,000 | SEC↗ |
| AAVL Avalanche Biotechnologies, | A Award deriv | 2015-04-21 | 2015-04-23 | 20,000 | — | $0 | 20,000 | SEC↗ |
| AAVL Avalanche Biotechnologies, | A Award | 2015-04-21 | 2015-04-23 | 7,000 | — | $0 | 7,000 | SEC↗ |
| AAVL Avalanche Biotechnologies, | S Sale | 2015-04-21 | 2015-04-23 | 1,000 | $39.21 | $39.2K | 0 | SEC↗ |
| AAVL Avalanche Biotechnologies, | M Exercise | 2015-04-21 | 2015-04-23 | 1,000 | $2.75 | $2.8K | 1,000 | SEC↗ |
| AAVL Avalanche Biotechnologies, | M Exercise deriv | 2015-04-14 | 2015-04-15 | 1,000 | — | $0 | 100,000 | SEC↗ |
| AAVL Avalanche Biotechnologies, | M Exercise | 2015-04-14 | 2015-04-15 | 1,000 | $2.75 | $2.8K | 1,000 | SEC↗ |
| AAVL Avalanche Biotechnologies, | S Sale | 2015-04-14 | 2015-04-15 | 1,000 | $39.45 | $39.5K | 0 | SEC↗ |
| AAVL Avalanche Biotechnologies, | M Exercise deriv | 2015-04-07 | 2015-04-08 | 9,000 | — | $0 | 101,000 | SEC↗ |
| AAVL Avalanche Biotechnologies, | M Exercise | 2015-04-07 | 2015-04-08 | 9,000 | $2.75 | $24.8K | 9,000 | SEC↗ |
| AAVL Avalanche Biotechnologies, | S Sale | 2015-04-07 | 2015-04-08 | 8,708 | $38.59 | $336.0K | 292 | SEC↗ |
| AAVL Avalanche Biotechnologies, | S Sale | 2015-04-07 | 2015-04-08 | 292 | $39.06 | $11.4K | 0 | SEC↗ |
| AAVL Avalanche Biotechnologies, | A Award deriv | 2014-07-30 | 2014-08-01 | 70,000 | — | $0 | 70,000 | SEC↗ |